312 related articles for article (PubMed ID: 27710158)
1. Hypertriglyceridemia: the importance of identifying patients at risk.
Kushner PA; Cobble ME
Postgrad Med; 2016 Nov; 128(8):848-858. PubMed ID: 27710158
[TBL] [Abstract][Full Text] [Related]
2. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
3. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
Ito MK
Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
[TBL] [Abstract][Full Text] [Related]
4. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
Breuer HW
Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
[TBL] [Abstract][Full Text] [Related]
5. Hypertriglyceridemia and cardiovascular risk reduction.
Jacobson TA; Miller M; Schaefer EJ
Clin Ther; 2007 May; 29(5):763-777. PubMed ID: 17697898
[TBL] [Abstract][Full Text] [Related]
6. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
7. Cumulative non-HDL-cholesterol burden in patients with hypertriglyceridemia receiving long-term fibrate therapy: Real life data from a lipid clinic cohort.
Kayıkçıoğlu M; Shahbazova S; İbrahimov F; Can LH
Turk Kardiyol Dern Ars; 2020 Jun; 48(4):359-367. PubMed ID: 32519982
[TBL] [Abstract][Full Text] [Related]
8. Management of hypertriglyceridemia in the diabetic patient.
Jialal I; Amess W; Kaur M
Curr Diab Rep; 2010 Aug; 10(4):316-20. PubMed ID: 20532703
[TBL] [Abstract][Full Text] [Related]
9. Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for clinicians.
Bays H
Drugs Today (Barc); 2008 Mar; 44(3):205-46. PubMed ID: 18536782
[TBL] [Abstract][Full Text] [Related]
10. [Lipid therapy in patients with diabetes].
Saely CH; Drexel H
Wien Med Wochenschr; 2010 Jan; 160(1-2):25-9. PubMed ID: 20229158
[TBL] [Abstract][Full Text] [Related]
11. Niacin and fibrate use among patients with high triglycerides and low high-density lipoprotein cholesterol.
Toth PP; Zarotsky V; Sullivan JM; Laitinen D
Curr Med Res Opin; 2009 Jun; 25(6):1355-63. PubMed ID: 19425901
[TBL] [Abstract][Full Text] [Related]
12. Effect of Combination Cholesterol-Lowering Therapy and Triglyceride-Lowering Therapy on Medical Costs in Patients With Type 2 Diabetes Mellitus.
Nichols GA; Reynolds K; Olufade T; Kimes TM; O'Keeffe-Rosetti M; Sapp DS; Anzalone D; Fortmann SP
Am J Cardiol; 2017 Feb; 119(3):410-415. PubMed ID: 27890243
[TBL] [Abstract][Full Text] [Related]
13. Statins and beyond: concurrent strategies for prevention of cardiovascular disease in patients with type 2 diabetes.
Standl E
Diab Vasc Dis Res; 2013 Mar; 10(2):99-114. PubMed ID: 22718811
[TBL] [Abstract][Full Text] [Related]
14. Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor.
Tenenbaum A; Klempfner R; Fisman EZ
Cardiovasc Diabetol; 2014 Dec; 13():159. PubMed ID: 25471221
[TBL] [Abstract][Full Text] [Related]
15. Is hypertriglyceridemia atherogenic?
Roubille F; Sultan A; Huet F; Leclercq F; Macia JC; Gervasoni R; Delseny D; Akodad M; Roubille C
Presse Med; 2018 Sep; 47(9):757-763. PubMed ID: 30262206
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia.
Maki KC; Guyton JR; Orringer CE; Hamilton-Craig I; Alexander DD; Davidson MH
J Clin Lipidol; 2016; 10(4):905-914. PubMed ID: 27578122
[TBL] [Abstract][Full Text] [Related]
17. Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidence.
Maki KC; Bays HE; Dicklin MR
J Clin Lipidol; 2012; 6(5):413-26. PubMed ID: 23009777
[TBL] [Abstract][Full Text] [Related]
18. Management of Mild-to-Moderate Hypertriglyceridemia.
Pulipati VP; Brinton EA; Hatipoglu B
Endocr Pract; 2022 Nov; 28(11):1187-1195. PubMed ID: 35850450
[TBL] [Abstract][Full Text] [Related]
19. Bridging the gap in treatment options for patients with hypertriglyceridemia.
Underberg JA; Hays R
J Fam Pract; 2007 Dec; 56(12 Suppl New):S24-31. PubMed ID: 18664339
[TBL] [Abstract][Full Text] [Related]
20. Hypertriglyceridemia: management of atherogenic dyslipidemia.
Bersot T; Haffner S; Harris WS; Kellick KA; Morris CM
J Fam Pract; 2006 Jul; 55(7):S1-8. PubMed ID: 16822443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
